Deep Track Capital, LP

Position in GHRS — GH Research PLC

CIK 1856083 GREENWICH, CT

Position in GHRS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$89,600,017

+$71,725,017 QoQ

Shares Held

3,333,334

+166.7% QoQ

Ownership

4.86%

of shares outstanding

% of Portfolio

1.36%

of 13F equity value

Holder Rank

of 62 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. GHRS ranks #25 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IMVT	Immunovant, Inc.	9,341,151	$359,914,548
2	GPCR	Structure Therapeutics Inc.	4,740,072	$254,399,664
3	PCVX	Vaxcyte, Inc.	4,300,000	$249,959,000
4	ALNY	Alnylam Pharmaceuticals, Inc.	825,000	$248,349,750
5	MANE	Veradermics, Inc	2,000,000	$245,880,000
6	TARS	Tarsus Pharmaceuticals, Inc.	3,666,768	$230,786,377
7	OCUL	Ocular Therapeutix, Inc	19,686,282	$193,319,289
8	BMRN	Biomarin Pharmaceutical Inc	3,307,481	$189,254,062

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$89,600,017	3,333,334	+166.7%	Shares	Sole	2026-08-14
2025-09-30	$17,875,000	1,250,000	-37.5%	Shares	Sole	2025-11-14
2025-06-30	$24,380,000	2,000,000	0.0%	Shares	Sole	2025-08-14
2025-03-31	$22,060,000	2,000,000	+300.5%	Shares	Sole	2025-05-15
2023-12-31	$2,896,520	499,400	0.0%	Shares	Sole	2024-02-14
2023-09-30	$5,018,970	499,400	0.0%	Shares	Sole	2023-11-14
2023-06-30	$5,925,381	499,400	0.0%	Shares	Sole	2023-09-06
2023-03-31	$3,990,206	499,400	0.0%	Shares	Sole	2023-05-15
2022-12-31	$4,854,168	499,400	0.0%	Shares	Sole	2023-02-14
2022-09-30	$5,803,028	499,400	0.0%	Shares	Sole	2022-11-14
2022-06-30	$4,984,012	499,400	0.0%	Shares	Sole	2022-08-12
2022-03-31	$9,134,026	499,400	0.0%	Shares	Sole	2022-05-16
2021-12-31	$11,651,002	499,400	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.